Search Press releases Keywords From To 8 Aug 2024 Transparency notification Goldman Sachs Read More 7 Aug 2024 Transparency notification Goldman Sachs Read More 5 Aug 2024 UCB announces European Commission approval for 320 mg device presentations of BIMZELX[®]▼(bimekizumab) Read More 25 Jul 2024 Strong Start into UCB’s Decade of Growth Read More 28 Jun 2024 Acquisition of own shares Read More 28 Jun 2024 UCB spotlights new analyses and patient insights supporting its recently launched gMG portfolio at the 10th Congress of the European Academy of Neurology (EAN) Read More Pagination First page Previous page Previous … Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Page 24 Page 25 Page 26 … Page 22 of 65 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe